MK-8294
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 30, 2025
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
(clinicaltrials.gov)
- P1 | N=47 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Oncology • Solid Tumor
June 27, 2025
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
(clinicaltrials.gov)
- P1 | N=47 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1